Sam G. Mostafa

South Yarra, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A Review of Virtual Twins in Physiologically-Based Pharmacokinetic Modeling and Simulation.

A Review of Virtual Twins in Physiologically-Based Pharmacokinetic Modeling and Simulation.

Journal: Clinical pharmacology and therapeutics
Published: February 15, 2026

Performance evaluation of Eu2NiMnO6-based lead-free perovskite solar cells: a SCAPS-1D study.

Performance evaluation of Eu2NiMnO6-based lead-free perovskite solar cells: a SCAPS-1D study.

Journal: RSC advances
Published: July 24, 2025

Multiscale analysis of Rb2NaInI6: from electronic structure to device performance for next-generation perovskite solar cells.

Multiscale analysis of Rb2NaInI6: from electronic structure to device performance for next-generation perovskite solar cells.

Journal: RSC advances
Published: July 03, 2025

Optimizing Cs2CuBiBr6 double halide perovskite for solar applications: the role of electron transport layers in SCAPS-1D simulations.

Optimizing Cs2CuBiBr6 double halide perovskite for solar applications: the role of electron transport layers in SCAPS-1D simulations.

Journal: RSC advances
Published: December 03, 2024

Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia.

Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophrenia.

Journal: CPT: pharmacometrics & systems pharmacology
Published: July 18, 2023

Consistent terminology for medication-related problems in pharmacogenomic cases.

Consistent terminology for medication-related problems in pharmacogenomic cases.

Journal: Journal of psychiatry & neuroscience : JPN
Published: May 12, 2023

Cytochrome P450-2D6 activity in people with codeine use disorder.

Cytochrome P450-2D6 activity in people with codeine use disorder.

Journal: The pharmacogenomics journal
Published: February 24, 2023

Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing.

Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing.

Journal: Pharmacogenomics
Published: September 28, 2022

Delineating gene-environment effects using virtual twins of patients treated with clozapine.

Delineating gene-environment effects using virtual twins of patients treated with clozapine.

Journal: CPT: pharmacometrics & systems pharmacology
Published: July 04, 2022

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.

Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.

Journal: Frontiers in psychiatry
Published: June 12, 2021

Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients.

Use of antidepressants with pharmacogenetic prescribing guidelines in a 10-year depression cohort of adult primary care patients.

Journal: Pharmacogenetics and genomics
Published: May 21, 2020

Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity.

Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity.

Journal: The pharmacogenomics journal
Published: January 21, 2019
Showing 1-12 of 14

Last Updated: 09/26/2026